Literature DB >> 6932175

Phagocytosis in myeloproliferative disorders.

J Corberand, P LaHarrague, B De Larrard, F Nguyen, J Pris.   

Abstract

The phagocytic function was investigated by means of four tests (capillary tube random migration, phagocytosis of yeast particles, quantitative nitroblue tetrazolium dye reduction and whole-blood bactericidal activity for Staphylococcus aureus) in 57 patients who had myeloproliferative disorders: 24 had chronic granulocytic leukemia, 22 had polycythemia vera, six had myelofibrosis, and five had essential thrombocythemia. This study confirms the previously reported functional anomalies of phagocytosis in all the myeloproliferative disorders and shows that, despite these anomalies, the increased number of phagocytes allows an efficient whole-blood bactericidal activity, essential for the nonspecific host defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932175     DOI: 10.1093/ajcp/74.3.301

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythaemia.

Authors:  N B Westwood; E R Copson; L A Page; A R Mire-Sluis; K A Brown; T C Pearson
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

2.  Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activity.

Authors:  M Amar; N Amit; C Babin-Chevaye; T P Huu; J Hakim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Glutathione reductase and nitroblue tetrazolium reduction deficiencies in neutrophils of patients with primary idiopathic myelofibrosis.

Authors:  A Perianin; M T Labro-Bryskier; C Marquetty; J Hakim
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.